Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113461578B reveals green aqueous synthesis using ytterbium catalyst. Reduces cost and lead time for high-purity pharmaceutical intermediates and fine chemical manufacturing.
Patent CN115894498A reveals a high-yield route for antiviral intermediate BL. Discover cost-effective manufacturing and scalable supply chain solutions for nucleoside analogs.
Patent CN118239888A reveals a light-induced modular synthesis for high-purity acridine compounds, offering significant cost reduction and supply chain reliability for photocatalyst manufacturing.
Patent CN104003828B details a copper complex catalyzed coupling reaction under visible light, offering cost reduction in fine chemical manufacturing and high-purity intermediates.
Patent CN111574450A details novel chiral biphenyl catalysts enabling high-yield asymmetric alkylation with reduced costs and superior supply chain reliability for pharmaceutical intermediates.
Patent CN106748906A details high-yield Bumetanide synthesis using Lewis acid. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Novel preparation method for spirocyclic indole diphenols via Eaton reagent cyclization. Offers cost-effective route for chiral catalyst precursors with high scalability.
Patent CN112028806B reveals a novel synthetic method for Vildagliptin intermediates, achieving 99.7% purity and 80.6% yield through stabilized cyanuric chloride dehydration.
Novel L-arginine catalyzed Henry reaction in water. High yield, eco-friendly, scalable for pharmaceutical intermediates manufacturing.
Patent CN111892559B details a high-yield asymmetric epoxidation of chalcones using chiral TADDOL ligands and rare earth metal amides, offering significant cost reduction in chiral epoxide manufacturing.
Novel two-step route using bis-ketal glucose enables high-purity chiral monomers for reusable polymer-supported asymmetric catalysis applications.
Patent CN103497227B reveals a mild epoxidation method for tulathromycin intermediates, offering significant supply chain stability and cost reduction benefits.
Patent CN108586283B reveals a green visible-light method using Rose Bengal, eliminating metal oxidants for safer pharmaceutical intermediate manufacturing.
Novel preparation method offers high yield and low waste for agrochemical and pharmaceutical intermediates supply chain optimization.
Patent CN112708641A discloses a high-efficiency chemo-enzymatic route for tomoxetine. Achieves >99.9% ee and high substrate loading for cost-effective manufacturing.
Patent CN115611695B reveals metal-free synthesis for substituted naphthalene derivatives. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN119431386A reveals photocatalytic synthesis enabling cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable green chemistry processes.
Novel phosphate-modified catalyst enables high-yield production of HIV drug intermediate with improved optical purity and scalable fixed-bed process technology for global supply chains.
Novel asymmetric synthesis of antitumor pyrano-pyrazole derivatives via chiral phosphine catalysis. Offers high enantioselectivity and scalable routes for API intermediates.
Patent CN106831551B reveals ionic liquid method for sulfonylpyridines. High yield over ninety percent. Reduced waste. Reliable supply chain for agrochemical and pharma intermediates.